This announcement is a separate document:
景峰医药：摩根士丹利证券（中国）有限公司关于湖南景峰医药股份有限公司公司债券受托管理事务临时报告
Jingfeng Pharmaceutical: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the corporate bond fiduciary management of Hunan Jingfeng Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.